A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Cholesterol-Lowering Effect of BBR 4401 in Adults with Moderate Hypercholesterolemia

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Cholesterol-Lowering Effect of BBR 4401 in Adults with Moderate Hypercholesterolemia

A randomized, double-blind, placebo-controlled trial was designed to assess the efficacy of the parabiotic <i>Bifidobacterium breve</i> IDCC 4401, named BBR 4401, for lowering cholesterol levels. The 66 subjects (per protocol set, n = 60) with low-density lipoprotein-cholesterol (LDL-C)...

Full description

Bibliographic Details
Main Authors: Mincheol Kim, Minjee Lee, Min-Goo Kim, Hayoung Kim, Boyoung Choi, Seongsik Kim, Won-Yeong Bang, Yong-Jin Kim, Jungwoo Yang, Hyun-Jae Kang
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Fermentation
Subjects:
<i>Bifidobacterium breve</i>
probiotics
parabiotics
cholesterol
bile acid
hypercholesterolemia
Online Access:https://www.mdpi.com/2311-5637/9/8/766

Internet

https://www.mdpi.com/2311-5637/9/8/766

Similar Items